(Q36075213)

12 August 2017

1 reference

title

Pulmonary rehabilitation in chronic obstructive pulmonary disease. (English)

1 reference

chronic obstructive pulmonary disease

12 August 2017

1 reference

1

Thierry Troosters

1 reference

12 August 2017

4

Marc Decramer

1 reference

12 August 2017

2

Richard Casaburi

1 reference

12 August 2017

Rik Gosselink

3

1 reference

PubMed ID

15778487

12 August 2017

language of work or name

English

0 references

publication date

18 March 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

12 August 2017

20

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

172

1 reference

12 August 2017

19-38

1 reference

12 August 2017

1

1 reference

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

12 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

21 January 2018

Pulmonary rehabilitation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Lung function 5 yr after lung volume reduction surgery for emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Inspiratory muscle training combined with general exercise reconditioning in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Results of a home-based training program for patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of training on the tolerance to high-intensity exercise in patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise training improves exertional dyspnea in patients with COPD: evidence of the role of mechanical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient!

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Randomised controlled trial of rehabilitation in chronic respiratory disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Randomised controlled trial of respiratory rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Long-term effects of outpatient rehabilitation of COPD: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Contemporary management of chronic obstructive pulmonary disease: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Efficiency of cold passover and heated humidification under continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of exercise training on older patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Benefits of an inpatient pulmonary rehabilitation program: a prospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Clinical research in chronic obstructive pulmonary disease: needs and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The components of a respiratory rehabilitation program: a systematic overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Pulmonary hypertension in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Disorders of the respiratory muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Quadriceps Fatigability after Single Muscle Exercise in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Evaluation of a movement detector to measure daily activity in patients with chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Aerobic and strength training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Resistance versus endurance training in patients with COPD and peripheral muscle weakness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Genes and human elite athletic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise training in COPD patients: the basic questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Reduced Mechanical Efficiency in Chronic Obstructive Pulmonary Disease but Normal Peak V̇o2with Small Muscle Mass Exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Maximum intensity exercise training in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Mechanisms by which COPD affects exercise tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Blood lactate changes in men during graded workloads at normal atmospheric pressure (100 kPa) and under simulated caisson conditions (400 kPa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

21 January 2018

Noninvasive Ventilation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Acute effects of inspiratory pressure support during exercise in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of respiratory muscle unloading on exercise-induced diaphragm fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Noninvasive ventilation during exercise training improves exercise tolerance in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Interval training as an alternative modality to continuous exercise in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The effects of resistance training on functional outcomes in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Reversal of COPD-associated weight loss using the anabolic agent oxandrolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of androgenic-anabolic steroids in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Testosterone supplementation therapy for older men: potential benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Sarcopenia--consequences, mechanisms, and potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The diaphragm in COPD. Better than expected, but not good enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Maintenance of inspiratory muscle training in COPD patients: one year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise training in COPD: how to distinguish responders from nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Individual differences in response to regular physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Predictors of improvement in the 12-minute walking distance following a six-week outpatient pulmonary rehabilitation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise training improves outcomes of a dyspnea self-management program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Self-management education for patients with chronic obstructive pulmonary disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Loneliness, depression, and social support of patients with COPD and their spouses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

"The Hidden Client"--women caring for husbands with COPD: their experience of quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Mechanisms of improvement in exercise capacity using a rollator in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Economic analysis of respiratory rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Occupational therapy and pulmonary rehabilitation of disabled COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Altered amino acid metabolism in chronic obstructive pulmonary disease: new therapeutic perspective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

ATS/ACCP Statement on cardiopulmonary exercise testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Bioelectrical impedance analysis--part I: review of principles and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Assessing the minimal important difference in symptoms: a comparison of two techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

"Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Exercise training during rehabilitation of patients with COPD: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Medicaid payment for telerehabilitation 1 1No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the author(s) or on any organization with which the author(s) is/

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

The ACE Gene and Endurance Performance during the South African Ironman Triathlons

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1109SO

10.1164/RCCM.200408-1109SO

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15778487